Drugs / PURETHAL Mites
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT01438463 | Sep 2011 → May 2013 | allergic rhinitis | HAL Allergy | Completed | No outcome recorded |
| Phase 2 | NCT00973453 | Aug 2009 → Aug 2010 | allergic rhinitis | HAL Allergy | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03209245 Comparator | Apr 2014 → Jun 2016 | — | Medical University of Silesia | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PURETHAL Mites | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01438463 ↗ |
| Route | Subcutaneous | “will be administered by subcutaneous injection” NCT01438463 ↗ |